Literature DB >> 11401050

Is overall asthma control being achieved? A hypothesis-generating study.

E D Bateman1, J Bousquet, G L Braunstein.   

Abstract

The efficacy of asthma therapy is traditionally measured using single end-points. In contrast, the aim of therapy is to achieve overall control, defined by management guidelines as achieving a number of treatment goals. These goals reflect expert opinion, rather than being evidence based. The objective of this study was to determine whether guideline-defined asthma control is achievable. Eight studies of salmeterol/fluticasone propionate combination therapy were analysed using three asthma control measures of varying stringency, derived from the guideline goals. For each measure, only patients meeting all goals were classified as controlled. The analysis demonstrated that asthma control, as defined by management guidelines, can be achieved. For a given therapy, similar proportions of patients achieved control irrespective of disease severity, suggesting that outcome expectations should not be reduced for patients with more severe disease. Substantially more patients achieved the target values for individual goals than achieved overall control, indicating that reliance on individual end-points is likely to result in significant overestimation of true control. The findings of this hypothesis-generating study should be prospectively tested. Future research will include a randomized controlled study designed to assess the proportion of patients able to achieve overall control of asthma when treatment is titrated appropriately.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401050     DOI: 10.1183/09031936.01.17405890

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Assessing asthma control.

Authors:  Elizabeth F Juniper
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

2.  Asthma control and management in the community: indices in 1997 compared with indices in 2002.

Authors:  Robert L Cowie; Margot F Underwood; Don D Sin; Heather M Sharpe; Neil R Bell; S F Paul Man
Journal:  Can Fam Physician       Date:  2006-06       Impact factor: 3.275

3.  Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Authors:  C Vogelmeier; I Naya; J Ekelund
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

Review 4.  Categorizing asthma severity: an overview of national guidelines.

Authors:  Gene L Colice
Journal:  Clin Med Res       Date:  2004-08

Review 5.  Measures of asthma control.

Authors:  Christian Bime; Jessica Nguyen; Robert A Wise
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

6.  Development of an economic model to assess the cost effectiveness of asthma management strategies.

Authors:  Martin J Price; Andrew H Briggs
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 7.  Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.

Authors:  Neil A Reynolds; Katherine A Lyseng-Williamson; Lynda R Wiseman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  GOAL: What Have We Learned?

Authors:  Timothy K Vander Leek
Journal:  Allergy Asthma Clin Immunol       Date:  2005-09-15       Impact factor: 3.406

9.  Socioeconomic factors and asthma control in children.

Authors:  Shannon F Cope; Wendy J Ungar; Richard H Glazier
Journal:  Pediatr Pulmonol       Date:  2008-08

10.  Factors associated with poor asthma control in children aged five to 13 years.

Authors:  S L McGhan; C MacDonald; D E James; P Naidu; E Wong; H Sharpe; P A Hessel; A D Befus
Journal:  Can Respir J       Date:  2006 Jan-Feb       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.